-
HUVEC – Human Umbilical Vein Endothelial Cells, Single Donor, in EGM™Catalog #: CC-2517
Cryopreserved ampule of Human Human Umbilical Vein Endothelial Cells (HUVEC) from a single donor containing ≥ 500,000 cells
Sales unit: each -
HUVEC – Human Umbilical Vein Endothelial Cells, Pooled, in EGM™Catalog #: CC-2519
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, containing ≥ 500,000 cells
Sales unit: each -
HUVEC-XL – Human Umbilical Vein Endothelial Cells, Large Volume, PooledCatalog #: 00191027HUVEC-XL, Pooled, ≥10 million cells/vialSales unit: Ampule
-
HUVEC – Human Umbilical Vein Endothelial Cells, Single Donor, in EGM™-2, Prescreened for AngiogenesisCatalog #: C2517ASHUVEC, single donor, in EGMTM-2, Pre-screened for angiogenesisSales unit: Ampule
-
HUVEC – Human Umbilical Vein Endothelial Cells, Pooled, in EGM™-2, Prescreened for AngiogenesisCatalog #: C2519AS
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells
Sales unit: Ampule -
PrEGM™ Prostate Epithelial Cell Growth Medium BulletKit™Catalog #: CC-3166
Culture system containing PrEBMTM Basal Medium (CC-3165) and PrEGMTM SingleQuotsTM Supplements (CC-4177) required for growth of Prostate Epithelial Cells
Sales unit: kit -
SF Cell Line 4D-Nucleofector® LV Kit XLCatalog #: V4LC-2020For larger scale transfection of cell lines, e.g. suspension CHO or HEK293, in the LV NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV UnitSales unit: kit
-
MEGMTM Mammary Epithelial Cell Growth Medium SingleQuotsTM KitCatalog #: CC-4136Supplements and growth factors required for the culture of Mammary Epithelial Cells (basal media not included)Sales unit: each
-
KuGMTM Kupffer Cell Culture Bullet KitTMCatalog #: MKC-500BK
Bullet KitTM consisting of basal medium plus supplements for culturing human Kupffer cells.
Sales unit: kit -
Cell Line Nucleofector™ Kit LCatalog #: VCA-1005
For efficient transfection of cell lines, e.g. 3T3-L1 ad, DU145, EL4, IMR-32 or MDCK, in the NucleofectorTM I/II/2b Device
Sales unit: items
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device SeriescGMP Cell Line Nucleofector Kit T
-
CAR-T Cells – Latest Advances and Outstanding Challenges